| Drugs with this side effect as MedDRA Preferred Term
			
			
	  	5-ASA
				
				
					Neutropenia: very rare, postmarketing 5-aza-2'-deoxycytidine
				
			5-azacytidine
				
				
					Neutropenia: very common, 2.7% - 65.7% A77 1726
				
			Anidulafungin
				
			BCNU
				
			CAS 76095-16-4
				
			CAS 76420-72-9
				
				
					Neutropenia: postmarketing Cancidas
				
			Carfilzomib
				
				
					Neutropenia: 0.76% - 20.7% Enfuvirtide
				
			FAMP
				
			FK463
				
				
					Neutropenia: 5.36% - 76.7% Ge-132
				
				
					Neutropenia: postmarketing K779
				
			Kaluril
				
			Lisinopril
				
				
					Neutropenia: very rare, postmarketing MDV3100
				
			Meropenem anhydrous
				
				
					Neutropenia: postmarketing Metrodin
				
			NSC 352122
				
			PCI-32765
				
			Romidepsin
				
			T-A2-3
				
			Vancocine
				
				
					Neutropenia: postmarketing Zyprexa Relprevv
				
			abacavir
				
			abacavir-lamivudine
				
			acetaminophen
				
			actinomycin D
				
			acyclovir
				
			albendazole
				
				
					Neutropenia: postmarketing allopurinol
				
			amantadine
				
			amiloride
				
				
					Neutropenia: postmarketing aminoglutethimide
				
			amiodarone
				
				
					Neutropenia: postmarketing amisulpride
				
				
					Neutropenia: postmarketing amoxicillin
				
			amprenavir
				
			anthracycline
				
			aprepitant
				
			aripiprazole
				
			arsenic
				
			arsenic trioxide
				
			asenapine
				
			atazanavir
				
			atovaquone
				
			auranofin
				
			axitinib
				
			azithromycin
				
				
					Neutropenia: postmarketing aztreonam
				
			benazepril
				
				
					Neutropenia: postmarketing benazeprilat
				
			bendamustine
				
			bexarotene
				
			bicalutamide
				
			boceprevir
				
				
					Neutropenia: very common, 10% - 19% bortezomib
				
			bosentan
				
				
					Neutropenia: postmarketing bosutinib
				
			busulfan
				
			cabazitaxel
				
			cabozantinib
				
			candesartan
				
				
					Neutropenia: postmarketing candesartan cilexetil
				
				
					Neutropenia: postmarketing capecitabine
				
			captopril
				
			carbenicillin
				
			carbimazole
				
			carboplatin
				
			cefaclor
				
				
					Neutropenia: postmarketing cefadroxil
				
			cefazolin
				
				
					Neutropenia: postmarketing cefdinir
				
				
					Neutropenia: postmarketing cefditoren
				
			cefepime
				
				
					Neutropenia: postmarketing cefixime
				
				
					Neutropenia: postmarketing cefotaxime
				
			cefotetan
				
			cefoxitin
				
			cefpodoxime
				
			cefprozil
				
			ceftaroline
				
			ceftazidime
				
			ceftizoxime
				
			ceftriaxone
				
				
					Neutropenia: postmarketing cefuroxime
				
				
					Neutropenia: postmarketing cefuroxime axetil
				
			cephalexin
				
			cephem
				
				
					Neutropenia: postmarketing chlorambucil
				
			chloroquine
				
			cidofovir
				
				
					Neutropenia: postmarketing, very common, 24.4% - 43.5% cilazapril
				
				
					Neutropenia: postmarketing cimetidine
				
			ciprofloxacin
				
			cladribine
				
			clarithromycin
				
				
					Neutropenia: postmarketing clindamycin
				
			clindamycin phosphate
				
			clofarabine
				
			clopidogrel
				
				
					Neutropenia: very rare, postmarketing, uncommon clozapine
				
			colchicine
				
				
					Neutropenia: postmarketing crizotinib
				
			cytarabine
				
			dabrafenib
				
			dalbavancin
				
			darunavir
				
			dasatinib
				
			deferasirox
				
				
					Neutropenia: postmarketing deferiprone
				
			delavirdine
				
			demeclocycline
				
			dexrazoxane
				
			diatrizoate
				
			diazepam
				
			dicloxacillin
				
			dimercaptosuccinic acid
				
			disopyramide
				
			docetaxel
				
				
					Neutropenia: very common, 1% - 95.5% dolutegravir
				
			doripenem
				
				
					Neutropenia: postmarketing, uncommon doxazosin
				
			doxorubicin
				
				
					Neutropenia: common, very common, 1.6% - 95.8% doxycycline
				
				
					Neutropenia: postmarketing doxycycline calcium
				
			doxycycline hyclate
				
			emtricitabine
				
				
					Neutropenia: postmarketing, common entecavir
				
				
					Neutropenia: postmarketing eribulin
				
			erlotinib
				
			ertapenem
				
			ethacrynic acid
				
			ethambutol
				
			etodolac
				
			etoposide
				
			everolimus
				
				
					Neutropenia: common, 0% - 46% famciclovir
				
			famotidine
				
			febuxostat
				
			fentanyl
				
			fidaxomicin
				
				
					Neutropenia: 1.03% - 2.48% flucloxacillin
				
			fluconazole
				
				
					Neutropenia: postmarketing fludarabine
				
			flurbiprofen
				
			fosamprenavir
				
			foscarnet
				
			fosinopril
				
			fosinoprilat
				
			fusidic acid
				
			ganciclovir
				
				
					Neutropenia: 11.8% - 25.7% gatifloxacin
				
			gemcitabine
				
				
					Neutropenia: very common, 0% - 89% haloperidol
				
				
					Neutropenia: very rare, postmarketing histamine
				
			hydralazine
				
			hydroxyurea
				
			ibuprofen
				
			idarubicin
				
			imatinib
				
				
					Neutropenia: postmarketing, very common, 0% - 100% iopamidol
				
			ioversol
				
			irbesartan
				
				
					Neutropenia: postmarketing irbesartan-hydrochlorothiazide
				
			irinotecan
				
			itraconazole
				
				
					Neutropenia: postmarketing ixabepilone
				
			lacosamide
				
			lamivudine
				
				
					Neutropenia: uncommon, 3% - 8% lamotrigine
				
				
					Neutropenia: postmarketing lansoprazole
				
				
					Neutropenia: postmarketing lapatinib
				
			leflunomide
				
			lenalidomide
				
				
					Neutropenia: postmarketing, very common, 33.4% - 79% lercanidipine
				
			levetiracetam
				
				
					Neutropenia: postmarketing lincomycin
				
			linezolid
				
			lurasidone
				
			lymecycline
				
			maraviroc
				
			mebendazole
				
			meclofenamate
				
			melphalan
				
			memantine
				
				
					Neutropenia: postmarketing mephenytoin
				
			meropenem
				
				
					Neutropenia: postmarketing metformin
				
			methotrexate
				
			methysergide
				
			metoclopramide
				
				
					Neutropenia: postmarketing metronidazole
				
			mexiletine
				
			mianserin
				
			miconazole
				
			milnacipran
				
				
					Neutropenia: postmarketing minocycline
				
			mirtazapine
				
			mitotane
				
			mitoxantrone
				
			moexiprilat
				
			moxifloxacin
				
			mycophenolate mofetil
				
			mycophenolic acid
				
				
					Neutropenia: postmarketing nafcillin
				
			nelarabine
				
			nelfinavir
				
				
					Neutropenia: postmarketing nevirapine
				
				
					Neutropenia: postmarketing, 8.9% - 9% nilotinib
				
				
					Neutropenia: very common, 11% - 42% norfloxacin
				
				
					Neutropenia: postmarketing ofatumumab
				
			ofloxacin
				
			olanzapine
				
				
					Neutropenia: postmarketing, rare, common olmesartan
				
			olsalazine
				
			omeprazole
				
				
					Neutropenia: postmarketing oxacillin
				
			oxaliplatin
				
				
					Neutropenia: very common, 0% - 82.2% oxcarbazepine
				
			oxytetracycline
				
			paclitaxel
				
				
					Neutropenia: rare, very common, 3% - 100% paliperidone
				
			pamidronate
				
			pazopanib
				
			pemetrexed
				
				
					Neutropenia: common, 0% - 58% penciclovir
				
			penicillin
				
			pentamidine
				
			perindopril
				
			perindopril erbumine
				
				
					Neutropenia: postmarketing perindoprilat
				
				
					Neutropenia: postmarketing piperacillin
				
			pixantrone
				
			pomalidomide
				
			ponatinib
				
			posaconazole
				
				
					Neutropenia: 3.05% - 16.3% Neutropenia aggravatedpralatrexate
				
			prednisone
				
			pregabalin
				
			procainamide
				
			propranolol
				
			quetiapine
				
				
					Neutropenia: postmarketing quinidine
				
			rabeprazole
				
				
					Neutropenia: postmarketing radium
				
			raltegravir
				
			raltitrexed
				
			ramipril
				
			ranitidine
				
			rapamycin
				
				
					Neutropenia: postmarketing regorafenib
				
			retigabine
				
			retinoic acid
				
				
					Neutropenia: postmarketing ribavirin
				
				
					Neutropenia: very common, 1% - 40% rifabutin
				
			rifapentine
				
			rifaximin
				
			riluzole
				
			risperidone
				
				
					Neutropenia: postmarketing ritonavir
				
			rufinamide
				
			ruxolitinib
				
				
					Neutropenia: very common, 1.9% - 18.7% saquinavir
				
			sodium cromoglycate
				
			sofosbuvir
				
				
					Neutropenia: very common, 0% - 17% sorafenib
				
				
					Neutropenia: postmarketing, common, 1% - 11% stavudine
				
				
					Neutropenia: very rare, postmarketing stiripentol
				
			streptozotocin
				
			sulfamethoxazole
				
			sulfasalazine
				
			sulindac
				
			sunitinib
				
				
					Neutropenia: postmarketing, 2% tacrolimus
				
				
					Neutropenia: postmarketing, uncommon tamoxifen
				
			telithromycin
				
			temozolomide
				
				
					Neutropenia: common, very common, 0% - 4% temsirolimus
				
			teniposide
				
			terbinafine
				
				
					Neutropenia: very rare, postmarketing tetracycline
				
			tetrahydrobiopterin
				
			thalidomide
				
				
					Neutropenia: postmarketing, 0.98% - 42.7% thymidine
				
			tigecycline
				
			tinidazole
				
			tipranavir
				
				
					Neutropenia: uncommon, 1% tofacitinib
				
			topiramate
				
				
					Neutropenia: very rare, postmarketing topotecan
				
				
					Neutropenia: very common, 1% - 97% trabectedin
				
			trametinib
				
			trandolapril
				
			trimethadione
				
			trimethoprim
				
			trimethoprim-sulfamethoxazole
				
			trimetrexate
				
				
					Neutropenia: 3.67% - 9.01% valganciclovir
				
			valproate
				
			valsartan
				
			vandetanib
				
			venlafaxine
				
				
					Neutropenia: very rare, postmarketing vincristine
				
			vinflunine
				
			vinorelbine
				
			vorinostat
				
			zafirlukast
				
			zalcitabine
				
			zanamivir
				
			zidovudine
				
			zidovudine/lamivudine
				
			zoledronic acid
				
			zuclopenthixol
				
			 | Drugs with this indication |